GlobeNewswire

ImvivaBio Presents Longer-Term Data from Clinical Studies of CTA313 Allogeneic CAR-T Therapy in Lupus at the American College of Rheumatology Convergence 2026
11/11/2026
BOSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- ImvivaBio, a clinical-stage biotechnology company developing next-generation allogeneic CAR-T cell therapies, today announced new research findings at the American College of [...]
Metagenomi Therapeutics, Inc. to Present at the Jefferies Global Healthcare Conference in London
11/11/2026
EMERYVILLE, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Metagenomi Therapeutics, Inc. (Nasdaq: MGX) (the “Company”), an in vivo genome editing company capitalizing on its proprietary technologies to create curative [...]
CenTrak Launches Mobile Capability to Extend Staff Safety Beyond Hospital Walls
11/11/2026
Duress RT Mobile expands staff protection across indoor, outdoor and off-site environments with real-time location visibility through a singularly connected incident management system NEWTOWN, Pa., Nov. 11, 2026 (GLOBE [...]
Wave Life Sciences to Present at Jefferies Global Healthcare Conference in London
11/11/2026
CAMBRIDGE, Mass., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Wave Life Sciences, Inc. (Nasdaq: WVE), a clinical-stage biotechnology company focused on unlocking the broad potential of RNA medicines to transform human health, [...]
Lexicon Pharmaceuticals to Present at the Jefferies Global Healthcare Conference in London
11/11/2026
THE WOODLANDS, Texas, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Lexicon Pharmaceuticals, Inc. (Nasdaq: LXRX), a leading cardiometabolic biopharmaceutical company, today announced that Company management will participate in a [...]
Ultragenyx to Participate at Investor Conferences in London
11/11/2026
NOVATO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra [...]
J-Star Holding Reaffirms 50-Year Advanced Composite Craftsmanship and Executive Financial Commitment, Highlighted by Tier 1 Carbon Fiber Supplier Partnership and Automated U.S. UAV Production
11/11/2026
TAICHUNG CITY, Taiwan, Nov. 11, 2026 (GLOBE NEWSWIRE) -- J-Star Holding Co., Ltd. (Nasdaq: YMAT) (“J-Star” or the “Company”), an innovator in advanced composite manufacturing, today issued a corporate update aimed at [...]
FDA Meeting Could Put NeOnc's NEO100 Experimental Brain Cancer Drug on Faster Track
11/11/2026
DENVER, Nov. 11, 2026 (GLOBE NEWSWIRE) -- ( 247MarketNews ) — NeOnc Technologies Holdings (NASDAQ: NTHI) secured a Type B End-of-Phase meeting, scheduled for early January 2027, with the U.S. Food and Drug [...]
Akari Therapeutics Participates in Virtual Investor “What This Means” Segment Featuring Newly Appointed Chief Business Officer Vatnak Vat-Ho
11/11/2026
Discussion highlights Vat-Ho’s oncology business development experience, his decision to join Akari and the potential of the Company’s novel PH1 payload platform Watch the “What This Means” video here TAMPA, Fla. and [...]
InnoCare Announces First Patient Dosed in Clinical Trial of Novel PSMA/ STEAP1 Bispecific ADC ICP-B381 in China
11/11/2026
BEIJING, Nov. 11, 2026 (GLOBE NEWSWIRE) -- InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company focusing on the treatment of cancer and autoimmune diseases, announced today that the first [...]
Tempest Therapeutics Exercises Option to License Senlang’s CD7-Targeted Lentiviral In Vivo CAR-T Platform Following Initial Phase 1 Results with Lead BCMA/GPRC5D Candidate
11/11/2026
-Tempest secures exclusive global rights outside China to a targeted lentiviral platform and portfolio of in vivo CAR-T candidates -Lead BCMA/GPRC5D dual-targeting in vivo CAR-T candidate evaluated in 13 patients with [...]
23andMe Research Institute and Scripps Research Translational Institute, a division of Scripps Research, Partner to Bring Genetics-Based Recruitment to Alzheimer's Prevention Research
11/11/2026
Partnership pairs 23andMe Research Institute's consented research community with novel Scripps Research-led Alzheimer's prevention study PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- 23andMe Research Institute [...]
Beeline Medicines Announces Presentation of Phase 2 Results of Afimetoran in Systemic Lupus Erythematosus at ACR Convergence 2026
11/11/2026
– All three afimetoran doses met the primary endpoint with a placebo-adjusted difference in SRI-4 response of more than 30 percentage points at Week 48 (p<0.001 for all doses) – – Secondary endpoints were [...]
NEXGEL Announces Noteholder Participation in Strategic Recapitalization and Approximately $1.2 Million in New Capital Funding
11/11/2026
Approximately 95% of Outstanding Convertible Note Principal Committed to Conversion, Subject to Completion of a Strategic Merger Sequence LifeScience ™ Provides $732,000, Representing 61% of Approximately $1.2 Million [...]
Ballipinar Dental Clinic to Bring Oral Health Advice to UK Patients During Mouth Cancer Action Month
11/11/2026
As more than 11,000 people are diagnosed with mouth cancer in the UK each year, the Antalya-based dental clinic highlights overlooked warning signs ahead of its Newcastle and Middlesbrough patient events LONDON, Nov. 11 [...]
Novo commits USD 200 million over 10 years to support the World Diabetes Foundation to strengthen diabetes prevention and care
11/11/2026
Bagsværd, Denmark, 11 November 2026 – Novo Nordisk today announced a USD 200 million commitment to the World Diabetes Foundation (WDF) for 2027–2036. Announced ahead of World Diabetes Day (14 November), the funding will [...]
The savings that cost more: new report puts a number on Europe's innovation choice
11/11/2026
This release is intended for the general public , healthcare professionals, policymakers and other healthcare decision-makers , plus pharmaceutical, policy and trade media. New analysis of five EU countries as well as [...]
Pharming to participate in fireside chat at Jefferies Global Healthcare Conference in London
11/11/2026
Leiden, the Netherlands, November 11, 2026: Pharming (Euronext Amsterdam: PHARM/Nasdaq: PHAR) today announced its participation in the 2026 Jefferies Global Healthcare Conference in London, United Kingdom, on November [...]
Devia Emerges from Stealth with an Agentic AI for GxP Pharma Quality Management
11/11/2026
After a year of building with manufacturing and quality teams, Devia spins out of Visium and is now available to the world’s largest biopharma companies, CDMOs and CROs, so every deviation gets solved once, not closed [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum